Huxley Medical Expands SANSA Platform with New Diagnostic Features
Huxley Medical has expanded its SANSA diagnostic platform with two new additions: SANSA GO and a cardiovascular risk marker called hypoxic burden, announced in a press release.
SANSA GO is a point of care enrollment model that allows clinics to provide the SANSA device directly during patient visits. It complements the existing SANSA Express home enrollment option and is designed to match the operational flexibility of cardiac monitoring programs. The SANSA platform, cleared by the FDA, measures electrocardiograms, obstructive sleep apnea, and central sleep apnea using a single chest patch.
The new hypoxic burden feature adds a measure of cardiovascular strain linked to sleep apnea. In a study of 325 patients, those with cardiovascular disease and arrhythmias were more than twice as likely to show elevated hypoxic burden levels. Findings from the study will be presented at the SLEEP 2026 meeting in Baltimore.
Both SANSA GO and the hypoxic burden feature will be available nationwide during the SLEEP 2026 meeting, scheduled for June 14 to 17.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Healthleap Raises $38 Million for Hospital Risk Screening AI
SPHERE HEALTH Opens Early Access to AI Hormonal Care Platform
Taiwanese Health Technology Groups Test US Market in Dallas
Cambridge Heartwear Wins £184 Million NHS Tender for ECG Wearable
SENA Health Raises Series A for AI Care Coordination
Daily AI Brief: the AI news that matters, in your inbox.